Venlafaxine (VLF)
Venlafaxine is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class. Multiple double blind studies show venlafaxine's effectiveness in treating depression. Venlafaxine has similar efficacy to the tricyclic antidepressants amitriptyline (Elavil) and imipramine, and is better tolerated than amitriptyline. Its efficacy is similar to or better than sertraline (Zoloft) and fluoxetine (Prozac), depending on the criteria and rating scales used. Higher doses of venlafaxine are more effective, and more patients achieved remission or were "very much improved". The efficacy was similar if the number of patients who achieved "response" or were "improved" was considered. A meta-analysis comparing venlafaxine and combined groups of SSRI or tricyclic antidepressants showed venlafaxine's superiority.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Venlafaxine (VLF) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Venlafaxine (VLF) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Venlafaxine (VLF) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Venlafaxine (VLF) CLIA Kit Customized Service Offer
n/a ELISA Kit for Venlafaxine (VLF) ELISA Kit Customized Service Offer